Hypotension SOB, Heart Failure (Quiz 2) Flashcards

1
Q

Heart failure & cardiogenic shock is defined as?

A

—A potentially life threatening condition where the heart is unable to pump sufficiently to supply oxygen-rich blood to meet the metabolic demands of the other organs in the body.
—➡️ inadequate tissue perfusion, end organ damage, and multi-system failure.
—Heart Failure may be the final manifestation of every form of other cardiac disease
—Cardiogenic shock carries a 40-70% mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Heart failure types
What is it relating to
How is it categorised nowadays

A

IMPAIR VENTRICULAR CONTRACTILITY
or
IMPAIR VENTRICULAR RELAXATION OR FILLING

—Systolic Heart Failure: impaired contractility
—Diastolic Heart Failure: impaired filling

There is overlap between the two processes therefore more common to define heart failure now as:

1️⃣ Heart Failure with reduced EF (<40%)
2️⃣ Heart Failure with preserved EF (>40%)

Normal EF is 55-60%
—amount of blood ejected from the left ventricle with each heartbeat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HF w/ reduced EF — why does the ventricle have diminished capacity to eject blood? 3

What are some causes?

A

The ventricle has a diminished capacity to eject blood due to:

1️⃣ Impaired myocardial contractility d/t destruction of myocytes, abnormal myocyte function, or fibrosis

2️⃣ Pressure overload (excessive afterload) — impairs the LV by increasing resistance to flow (HTN)

3️⃣ coronary artery disease

OTHER CAUSES relate to disease processes that affect:
—cardiac myocardium (MI, myocarditis, drugs)
—aorta (hypertension)
—valves
—electrical system (tachyarrhythmias)
—as well as congenital heart disease.
—rheumatologic systemic disease
—endocrine disorders
—pregnancy (peripartum cardiomyopathy)
—stress (takotsubo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HF w/ preserved EF (HFpEF)
What are the two broad causes? What are THEY causes by ?

A

Abnormalities with one of the following or BOTH:

1️⃣ Impaired early diastolic relaxation (energy dependent process)
—Diastolic early relaxation is usually related to a MI

2️⃣ Increased stiffness of the LV
—Left ventricular hypertrophy, fibrosis, or restrictive cardiomyopathy typically cause the LV to be chronically stiff
—Pericardial constriction and tamponade call also cause forms of diastolic dysfunction

Classic patient is older woman

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Right sided HF
What is the right ventricle susceptible to?
Common cause of r.sided HF?
Isolated r.sided HF results from?

A

—right ventricle is thin walled but highly compliant to accepting blood volume.
—susceptible to failure in situations that suddenly increase afterload

The MOST COMMON CAUSE of right sided HF is left sided heart failure.

Isolated right sided HF results from:
—pulmonary diseases aka COR PULMONALE d/t increased pulmonary artery pressures.

PULMONARY PARENCHYMAL DISEASE
—COPD
—interstitial lung disease
—bronchiectasis

PULMONARY VASCULAR DISEASE
—pulmonary embolism
—primary pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the compensatory mechanisms that activate in systolic HF? (HFrEF/Low EF) — 3
memorise the equation in the image

A

Three mechanisms help counter the drop in cardiac output and preserve sufficient blood pressure to perfuse vital organs:

  1. Frank-Starling Mechanism
    —With decreased CO, in a healthy heart, more blood comes in, more stretch, better snap/squeeze. Dehydration would be one reason for low SV. Increases pre-load. In a failing heart, this mechanism doesn‘t work.
  2. Neurohormonal Alterations notice decrease BP and activate:
    —Adrenergic nervous system
    —Renin-angiotensin-aldosterone system (RAAS)
    —Increased antidiuretic hormone (ADH/vasopressin)

causing more water retention, more vasoconstriction. These benefit at first but are detrimental in the long run

  1. Ventricular Hypertrophy and Remodeling
    —to increase contractility but it will fail over time
    —it makes the muscle stiff
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Frank-Starling
What is the mechanism here?

A

Stretch versus Snap = the greater the stretch, the more forceful the snap

In a failing heart however, the contractility (snap) is impaired.

Therefore more diastolic filling (stretch) results in a lower stroke volume than normal.

The residual volume induces a greater stretch on the myofibers in the subsequent beat, which helps empty the LV and preserve cardiac output.

This compensatory mechanism will eventually fail and the subsequent volume will go retrograde into the lower pressure left atrium and pulmonary pressures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Neurohormonal alterations

A

Activate in response to low cardiac output is to increase SYSTEMIC VASCULAR RESISTANCE which helps maintain arterial perfusion to vital organs
BP = CO x TPR
if cardiac output is low, increase TPR to increase BP to perfuse organs

Also increase salt and water retention which INCREASES INTRAVASCULAR VOLUME and LV PRELOAD, maximizing stroke volume via the Frank-Starling mechanism.

Beneficial acutely to preserve cardiac output however chronic activation of these mechanisms are devastating to the failing heart and contribute to a decline in cardiac output.

Harmful effects
—Increased volume and augmented venous return to the heart WORSEN congestive pulmonary systems
—Elevated arteriolar resistance INCREASES the load which the failing LV has to contract against DECREASING stroke volume and cardiac output
—Increased heart rate increases metabolic demand and reduced the performance of the left ventricle
—Continuous SYMPATHETIC activation results in DOWN REGULATION of B adrenergic receptors DECREASING the myocardium’s sensitivity to circulating catecholamines and REDUCED inotropic response
—Chronically elevated levels of AII (angiotensin II) and Aldosterone increase production of cytokines, activate macrophages, stimulate fibroblasts, and lead to FIBROSIS and ADVERSE/NEGATIVE REMODELING of the failing left ventricle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Beneficial neurohormonal alteration
Which peptides are released?
What is their effect?

A

NATRIURETIC PEPTIDES are natural hormones secreted in heart failure (congested & stressed) in response to INCREASED intracardiac pressures:

1️⃣ ANP or atrial natriuretic peptide released with atrial dilation

2️⃣ BNP B-type or brain natriuretic peptide is released when the ventricular myocardium is subject to hemodynamic stress or increased radius or pressure
—proBNP is a prohormone that generates both BNP and an inert N-terminal proBNP

RESULT is the EXCRETION of sodium and water, VASODILATION, INHIBITION of renin, and antagonize the effects of AII on aldosterone and vasopressin

Problem = they are INSUFFICIENT to counteract the effects of the other activated neurohormonal systems. True benefit is diagnostic but they can‘t really overcome the neurohormal systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ventricular hypertrophy & remodeling

A

1️⃣ LV Wall Stress increases due to chamber dilation or the need for greater pressure to overcome increased afterload

2️⃣ Myocardial Hypertrophy results to counter the effect of increased wall stress and maintain contractile force ➡️ increased LV stiffness & elevated diastolic pressures which then transmit retrograde
—Chronic volume overload leads to chamber dilation ➡️ new sarcomeres form in series with the old ones causing ELONGATION of myocytes and ECCENTRIC HYPERTROPHY
—Chronic pressure overload leads to the synthesis of new sarcomeres in parallel with the old ones causing THICKENING of the myocytes and CONCENTRIC HYPERTROPHY

3️⃣ Ultimately ventricular function will decline allowing the chamber to dilate out of proportion to wall thickness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Precipitating factors of HF
What factors tip a patient into decompensation? 6

A

—pts may be asymptomatic for extended periods of time because of either mild impairment or the result of the compensatory mechanisms.

Events that increase cardiac workload can tip them into DECOMPENSATION:

1️⃣ Increased Metabolic Demands:
—fever, infection, anemia, tachycardia, hypothyroidism, pregnancy

2️⃣ Increased Volume:
—excessive dietary sodium or fluids
—renal failure (pt misses dialysis)

3️⃣ Increased Afterload:
—uncontrolled hypertension, PE

4️⃣ Impaired Contractility:
—MI, drug induced (alcohol), negative inotropic agents

5️⃣ Failure to take prescribed medications
—in an exacerbation, if mildly congested, half their BB, if they‘re severe, hold the BB until they‘re euvolemic and then titration back up

6️⃣ Excessively slow heart rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the signs and symptoms of HF?

A

—Dyspnea (on exertion) and Orthopnea
—Paroxysmal Nocturnal Dyspnea (resorption of edema)
—Cheyne-Stokes Respiratory Pattern (advanced HF, tachypnea then period of apnea, then again)
—Fatigue and Confusion (low CO for cerebral perfusion)
—Palpitations
—Syncope
—Abdominal Pain/Nausea/Early Satiety (Ascites)
—Cool/Mottled Skin (low SV/CO, entering cardiogenic shock)
—Edema/Weight Gain
—Elevated JVD
—Ascites/Hepatomegaly (right sided HF, backs up into portal venous system. RUQ pain)
—S3 Gallop and Mitral/Tricuspid Regurgitation
—Tachycardia
—Hypotension
—Pulsus Alterans (one strong beat, followed by a weak beat)
—Decreased Urinary Output (kidneys not getting perfused, CO decrease, entering cardiogenic shock)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What could cause:
—warm and dry
—warm and wet
—cold and dry
—cold and wet

A

Systolic HF:
—warm and dry: normal
—warm and wet: most patients, not in shock, have HF, EF down, holding on to a lot of edema but still perfusing organs. Diurese and afterload reduce them
—cold and dry: cardiogenic shock
—cold and wet: cardiogenic shock, low output, not perfusing. Congested. Diurese these patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HF diagnostics — what do these tell you?

BMP

LFTs

CBC

BNP ⭐️ [know this]

Cardiac Enzymes

TSH

Drug Screen

Iron Studies

Lactate / VBG (pH)

EKG

Chest Radiograph

Echo

Coronary Angiography

A

BMP
—Hyponatremia = poor prognostic sign. HF patients are usually hypervolemic hyponatremic. They are congested
—Elevated BUN and Creatinine (cardiorenal syndrome/pre-renal = heart not perfusing kidney) with Hyperkalemia
—Hypokalemia and Hypomagnesemia = arrhythmia risk

LFTs
—Transaminitis from hepatic congestion or shock liver

CBC
—Anemia a/w increased mortality

BNP ⭐️
—Released in setting of increased ventricular dilation or wall stress (HF). Elevated

Cardiac Enzymes
—Rule out acute MI versus supply demand ischemia

TSH

Drug Screen

Iron Studies
—could be diastolic HF
—hemachromatosis

Lactate / VBG (pH)
—make sure not in lactic acidosis

EKG
—Presence of Q waves to indicate prior MI or acute ST segment changes for ongoing ischemia/injury
—Chamber enlargement:
—Hypertrophy or Low Voltage
—Conduction Disease (LBBB suggesting dyssynchrony)
—Atrial Arrhythmias

Chest Radiograph
—Heart Size
—Pulmonary Edema
—Pleural Effusions
—Rule Out Infection
—Lines

Echo — tells us the EF
—Most useful diagnostic test as provides extensive information about the structural condition of the heart allowing one to determine the etiology of heart failure/shock.
—Convenient and harmless study
—Evaluate for regional wall motion abnormality in setting of a coronary artery distribution to indicate ischemia
—Valvular Disease
—Non-ischemic Dilated Cardiomyopathy

Coronary Angiography
—Important to define the coronary anatomy to help determine etiology of heart failure
—If acute, early revascularization in patients with a myocardial infarction and shock has proved to have a mortality benefit in patients < 75 years of age and absence of contraindications.
—Ischemic disease is the number one cause of systolic HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diagnositics for shock

A

Right Heart Catheterization
—Pulmonary capillary wedge pressure (PCWP) > 15 mmHg
—Central venous pressure > 10 mmHg
—Decreased mixed venous oxygen saturation
—Cardiac index < 2.2 L/min/kg/m2

Systolic blood pressure < 90 mmHg for at least 30 minutes

generally reserved for very sick patients in the ICU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HF with Reduced EF - Management

A

Need to differentiate Acute and Chronic Management

If acute, determine if:
—cold and wet (shock)
—cold and dry (low output/shock)
—warm and wet (decompensated)

Management Strategy Guideline: [know]
—Preload
—Pump
—Afterload
—Devices

17
Q

HF with Reduced EF - Management
Shock requires?
If acutely decompensated but hemodynamically stable?

A

—Shock requires ICU level of care with IV medications and oxygen support (40-70% mortality)
—If acutely decompensated but hemodynamically stable, can admit to telemetry for IV diuretics and oral medications
Following management of acute heart failure, transition to chronic pharmacology

18
Q

What are the two paradigms to cardiogenic shock?

A

1️⃣ A drop in cardiac output resulting in hypotension, tachycardia, and compensatory increase in vasoconstriction/systemic vascular resistance to maintain tissue perfusion. Along spectrum of progression of systolic heart failure.

2️⃣ Acute drop in cardiac output causing SIRS like response with drop in systemic resistance similar to septic shock (20%).

19
Q

Treatment of shock
6

A

Inotropic Agents
—support a failing left ventricle (mechanical and electrical)
—see table of medications
—milrinone, dobutamine, dopamine frequently used

Vasodilators
—preload and afterload reduction

Vasopressors
—may be needed to maintain an effective mean arterial pressure
—if MAP is 45, you want 60, so might need to clamp down on BP to get organ perfusion

Diuretics

Ultrafiltration
—like dialysis to get volume off

Oxygen support / Noninvasive Positive Pressure Ventilation

20
Q

Treatment of shock
What are the additional adjunctive hemodynamic support therapies?
Intra-aortic balloon pump IABP
Percutaneous ventricular assist devices

A

1️⃣ Mechanical support from an Intra-aortic Balloon Pump (IABP): Reduces afterload, improves cardiac output, and augments diastole which improves coronary perfusion

2️⃣ Percutaneous Ventricular Assist Devices including the Tandem Heart and Impella. They can bridge to recovery or more definitive therapy. The TandemHeart provides left atrial to femoral artery bypass flow at rates up to 5 L/min. The Impella is an intracardiac ventricular flow device that can provide 2.5 to 5 L/min support.

21
Q

Treatment of shock
What are the additional adjunctive hemodynamic support therapies?
ECMO
LVAD

A

3️⃣ Extracorporeal Membrane Oxygenation (ECMO): Life support machine replacing the function of both the heart and lungs. The machine removes blood from the patient to an oxygenator which removes carbon dioxide and adds oxygen. The blood is then returned to the patient via a pump that circulates it through the body replacing the function of the heart.

4️⃣ Left Ventricular Assist Device (LVAD): Mechanical pump surgically implanted in patients to circulate blood while a patient awaits a transplant. One end of the pump is attached to the left ventricle and the other attaches to the aorta.

22
Q

HF w/ reduced EF — chronic management
10
What are the main 4?

A

Goal is to prevent negative remodeling (fibrosis) of the heart by the compensatory mechanisms and prolong survival.

Start with two, expand to four, lower doses then titrate up. Monitor.

  1. ACE-I or ARB or ARNI = Mortality benefit
  2. Beta blockers = Mortality Benefit. Metoprolol succinate or Carvedilol or Bisoprolol
    3.Aldosterone Receptor Antagonists = Mortality Benefit
  3. SGLT2 Inhibitors = Mortality Benefit. Has a diuretic component to it so might not even need diuretic (obv if they have diuretic SX/congestion, would probably need a diuretic
  4. ARNI (ARB/Neprolysin Inhibitor. Entresto < this is the goal/ideal b/c has the best evidence. Significant BP effect. But not always covered by insurance) = Mortality Benefit
  5. Ivabradine — Benefit in patients on above meds and HR > 70 bpm. Works on funny channel
  6. Diuretics — Needed for symptom management. No mortality benefit but never withhold it.
    8 Digoxin
    —Reduces rate of hospitalizations
    —Combination of Hydralazine/Nitrates = reduces mortality in African Americans when added to medical therapy including an ACE-I/ARB
  7. Device Therapy with a defibrillator
  8. Cardiac Resynchronization therapy with a BiV-ICD
23
Q

What are the five alive? (Or 4)

A

ACE, ARB or ARNI
BB
MRA (Aldo antagonist)
SGLT2 inhibitor

so really only 4

24
Q

HF w/ preserved HF
What is it? How is it defined?
How do you diagnose?
What is the typical patient demographic?
S/S?
What are the goals of therapy?

A

Nothing to do for this patients! Only can really help from a symptomic stand point.

impairment in LV relaxation and/or increased LV stiffness

Defined by:
—Signs and symptoms of congestive heart failure
LVEF > 40% and a non dilated left ventricle
—Evidence of elevated left ventricle filling pressures. Right sided cath. But normal CO.

Diagnosis made by:
—Specific echo findings
—Right heart catheterization measurements

Patient
—typically older and female.
—comorbidities include hypertension, diabetes, obesity, and chronic kidney disease.

Signs/Symptoms
—similar to those of HF with reduced EF (systolic HF)
—pts w/significant right sided heart failure features (ascites, hepatic congestion, peripheral edema), a restrictive cardiomyopathy or constrictive pericarditis diagnosis should be considered

Goals of therapy
—hypertension Control (believed to be the etiology in the majority of patients with HFpEF)
—diuretics for symptom relief
—rhythm control and rate control for arrhythmias. Keep out of Afib
—consider a catheterization to rule out ischemia
—low salt diet <2g/d
—weight loss and exercise training

There are NO medications currently that reduce all cause mortality in patients with diastolic dysfunction

25
Q

HF w/ preserved EF
Treatment

A

There are NO medications currently that reduce all cause mortality in patients with diastolic dysfunction.

Studies
EMPEROR-Preserved: Among adults with HF-pEF, empagliflozin decreased the risk of CV death and hospitalization (benefit derived from fewer hospitalizations)

TOPCAT: spironolactone does not reduce CV mortality but was associated with fewer HF hospitalizations

PARAGON-HF: ARNI did not lead to lower hospitalizations when compared to an ARB but did improve NYHA symptom class